Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study.
source https://www.sciencedaily.com/releases/2021/04/210411114048.htm
0 comments: